Concepedia

A. Armstrong

AA

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2022

Affiliations

Janssen (Belgium)(Current)

A. Armstrong is an author at Janssen (Belgium) specializing in psoriatic disease, dermatology, and tyrosine kinase inhibition.

Publications per year

2022–2022

1

Publications

1

AB0890 Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Moderate to Severe Plaque Psoriasis: 52-Week Efficacy Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Trials

Richard B. Warren, A. Armstrong, M. Gooderham et al. · Annals of the Rheumatic Diseases · 2022 · 10 citations · Full text

, , +12

1–1 of 1